Researchers showed that 1.34 mg of Fotivda provided decreased tumor size and may be more tolerable than an 0.89-mg dose among patients with renal cell carcinoma.
The Food and Drug Administration said it was taking the action because studies found that the dye, also known as erythrosine, ...
The FDA launches a bold strategy to prevent viral contamination in imported berries. Discover how this impacts food safety ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback